TF and Venous thrombosis: Overall, systemic miR-145 downregulation was associated with increased thrombus formation and TF expression, whereas treatment with miR-145 mimics effectively diminished both, highlighting the strong potential of miR-145-based therapies for managing venous thrombosis in humans [114].